Sunday, December 01, 2013 3:06:09 PM
Nov 27, 2013 (ACCESSWIRE via COMTEX) -- New York, November 27, 2013
Moving notably higher on the session are shares of beaten down pain management company Zalicus Inc ZLCS -2.42% . Volume is already more than double the 10-day average in the name.Still, the shares are ~75% below where they traded before news hit that Z160 did not meet its primary endpoint in two Phase 2 trials. The company is now pinning its hopes on Z944.Here's SA contributor Jason Napodano: "I spoke with management. Talked about a number of reasons why Z944 is different from Z160. Will share soon."
http://www.wired.com/gadgetlab/2012/08/apple-amazon-mat-honan-hacking/
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM